Tri Chemical Laboratories (TSE Prime: 4369) has raised its full-year profit guidance for the year to January 2027 after first-half results ran well ahead of the forecast it issued in March.
For the six months to July 31, 2026, the Uenohara, Yamanashi-based maker of high-purity chemicals for semiconductor manufacturing reported revenue of ¥14.7bn, 7.3% above its ¥13.7bn forecast. Operating profit came in at ¥3.84bn, nearly 30% ahead of plan, and net profit attributable to owners reached ¥3.37bn, 54% above the ¥2.19bn the company had guided. Half-year earnings per share hit ¥103.81 against a forecast ¥67.39.
Management named two specific causes. Semiconductor makers kept plants running at high utilization on demand tied to generative AI, and their capital spending pushed the company's shipments into the China and Taiwan chip markets above its original assumptions. Separately, strong memory production in Korea lifted results at equity-method affiliate SK Tri Chem Co., Ltd. beyond plan, adding investment gains that flow through ordinary profit rather than core operations.
Those regional patterns show up in the half's own revenue breakdown: external sales from China reached ¥5.84bn and from Taiwan ¥4.95bn, against ¥2.21bn from Japan and ¥1.28bn from Korea.
A 43% higher profit target
Because management expects these conditions to persist, Tri Chemical revised its full-year consolidated guidance alongside the interim results. It now targets revenue of ¥29.5bn, up 9.3% from the ¥27.0bn forecast set in March; operating profit of ¥7.45bn, up 24.2%; ordinary profit of ¥8.72bn, up 38.4%; and net profit attributable to owners of ¥6.57bn, up 42.8% from the earlier ¥4.6bn target. Full-year EPS guidance rises to ¥202.17 from ¥141.55.
| Metric | March Forecast | Revised Forecast | Change |
|---|---|---|---|
| Revenue | ¥27.0bn | ¥29.5bn | +9.3% |
| Operating profit | ¥6.0bn | ¥7.45bn | +24.2% |
| Ordinary profit | ¥6.3bn | ¥8.72bn | +38.4% |
| Net profit attributable to owners | ¥4.6bn | ¥6.57bn | +42.8% |
| EPS | ¥141.55 | ¥202.17 | — |
The revised net profit target is also 19.1% above the ¥5.52bn the company actually earned in the year to January 2026, when revenue was ¥23.9bn, according to its own guidance table.
Tri Chemical's notice carries its standard caveat that the forecast rests on information available now and that actual results may diverge for reasons the company has not itemized beyond the demand trends it cited. The company holds an analyst briefing on September 1 and is due to file its half-year securities report on September 14.